Showing results (711-720 of 857) with videos related to

Sort By:
Pageof 86
Cell Transplantation|March 5, 2021
Protective Effects of Human Nonrenal and Renal Stromal Cells and Their Conditioned Media in a Rat Model of Chronic Kidney DiseaseBarbara Imberti, Domenico Cerullo, Daniela Corna, et al.
Diabetes Research and Clinical Practice|February 27, 2022
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)Piero Ruggenenti, Monica Cortinovis, Matias Trillini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 30, 2026
Complement-Mediated Postpartum Atypical Hemolytic Uremic Syndrome With Collapsing Focal Segmental Glomerulosclerosis Associated With a Novel CFHR5 Copy Number VariantRossella Piras, Carolina Martinatto, Elena Bresin, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2014
Paricalcitol for secondary hyperparathyroidism in renal transplantationMatias Trillini, Monica Cortinovis, Piero Ruggenenti, et al.
Frontiers in Genetics|August 21, 2019
Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 DiabetesElisabetta Valoti, Marina Noris, Annalisa Perna, et al.
American Journal of Nephrology|December 15, 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy TrialFinnian R Mc Causland, Brian Claggett, Marc A Pfeffer, et al.
Plos One|March 7, 2012
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort studyPiero Ruggenenti, Flavio Gaspari, Antonio Cannata, et al.
Lancet (London, England)|June 4, 2013
Kidney failure: aims for the next 10 years and barriers to successGiuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.
Molecular Immunology|February 20, 2016
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcomeParaskevas Iatropoulos, Marina Noris, Caterina Mele, et al.
Plos Medicine|June 24, 2021
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trialPiero Ruggenenti, Paolo Cravedi, Eliana Gotti, et al.
Pageof 86